Concepedia

Ernest Medina

EM

Statistics

Publications

5

Citations

718

H-Index

5

Active since

2009

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

Takeda (Japan)

Millennium Engineering and Integration (United States)

Ernest Medina is an author at The University of Texas at San Antonio Health Science Center specializing in molecular oncology, pharmacology, and oncology.

Publications per year

2009–2011

5

Publications

5

Inhibition of NEDD8-activating enzyme: a novel approach for the treatment of acute myeloid leukemia

Ronan Swords, Kevin R. Kelly, Peter G. Smith et al. · Blood · 2010 · 277 citations · Full text

, , +7

Autophagy inhibition enhances vorinostat‐induced apoptosis <i>via</i> ubiquitinated protein accumulation

Jennifer S. Carew, Ernest Medina, Juan Esquivel et al. · Journal of Cellular and Molecular Medicine · 2009 · 221 citations · Full text

, , +17

Vorinostat Enhances the Activity of Temsirolimus in Renal Cell Carcinoma Through Suppression of Survivin Levels

Devalingam Mahalingam, Ernest Medina, Juan Esquivel et al. · Clinical Cancer Research · 2009 · 119 citations

, , +17

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib

Kevin R. Kelly, Jeffrey Ecsedy, Ernest Medina et al. · Journal of Cellular and Molecular Medicine · 2010 · 73 citations · Full text

, , +8

Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma

Devalingam Mahalingam, Claudia M. Espitia, Ernest Medina et al. · British Journal of Cancer · 2011 · 28 citations · Full text

, , +17

1–5 of 5